Page 166 - வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alzheimer’s Association Chief Scientific Officer Dr. Maria Carrillo explains what Alzheimer’s disease is and how much it costs the U.S. health care system. In the weeks since a new Alzheimer’s drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment that has sparked both excitement and skepticism. They want to know if the drug might be right for them. Like many physicians, Atri has no easy answers. It’s not a simple yes or no, said the neurologist at the Banner Sun Health Research Institute in Arizona. It probably won’t be for a while. Doctors across the country are still trying to figure out who should receive the drug called Aduhelm, which, at best, slows the fatal disease marginally. Other drugs for Alzheimer’s disease only temporarily ease symptoms like memory problems, insomnia and depression.

United statesCleveland clinicBusch gardensSuzanne schindlerAlireza atriKarl newkirkBabak tousiRonald petersenMichael greiciusMichele hallMaria carrilloStanford greiciusMichigan institute for neurological disordersBanner sun health research instituteDrug administrationAlzheimer association